| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Nicoumalone 1mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sinthrome 1mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Marevan 0.5mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Warfarin sodium 0.5mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Warfarin sodium 5mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Warfarin sodium 3mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Warfarin sodium 1mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Marevan 5mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Marevan 3mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Marevan 1mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Revasc 15mg injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Desirudin 15mg injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Refludan 50mg injection (pdr for recon) |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Lepirudin 50mg injection (pdr for recon) - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Alphaparin 3000iu/0.5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Alphaparin 3000iu/0.3mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Certoparin sodium 3000iu/0.5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Certoparin sodium 3000iu/0.3mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Danaparoid sodium 750iu/0.6mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Orgaran 750iu/0.6mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 2500iu/0.25mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 2500iu/0.25mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 20,000iu/2mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 20,000iu/2mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 4500iu/0.45mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 3500iu/0.35mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 4500iu/0.45mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 3500iu/0.35mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 18,000iu/0.9mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 14,000iu/0.7mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 10,000iu/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 18,000iu/0.9mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 14,000iu/0.7mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 10,000iu/0.5mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 5000iu/5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 5000iu/5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 40,000iu/2mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 40,000iu/2mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 5000iu/0.5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Tinzaparin sodium 3500iu/0.3mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 5000iu/0.5mL injection amp |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Innohep 3500iu/0.3mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Enoxaparin 150mg/1mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Enoxaparin 120mg/0.8mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Clexane Forte 150mg/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ancrod 70units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Arvin 70units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 1000units/10mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 200units/2mL patency solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 50units/5mL patency solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Canusal 200iu/2mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Hep-Flush 1000units/10mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heplok 50units/5mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Hepsal 50units/5mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Hep-Flush 200units/2mL patency solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 10,000iu/1mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Minihep Calcium 5000iu/0.2mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Minihep 5000iu/0.2mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 10,000iu/0.4mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 5000iu/0.2mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 5000iu/0.2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin calcium 20,000iu/0.8mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin calcium 12,500iu/0.5mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin calcium 5000iu/0.2mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin calcium 5000iu/0.2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Uniparin-Ca 12,500iu/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 10,000iu/4mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 10,000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 10,000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 10,000iu/4mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calciparine 20,000iu/0.8mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin-Ca 5000iu/0.2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Uniparin Forte 10,000iu/0.4mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 5000iu/0.2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 7500iu/0.3mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 7500iu/0.3mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 10,000iu/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 15,000iu/0.6mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 15,000iu/0.6mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 18,000iu/0.72mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 12,500iu/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 10,000iu/0.4mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 18,000iu/0.72mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 12,500iu/0.5mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 10,000iu/0.4mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fragmin 100,000iu/4mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dalteparin sodium 100,000iu/4mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Minihep Calcium 5000iu/0.2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Minihep 5000iu/0.2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calciparine 12,500iu/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calciparine 5000iu/0.2mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 20,000iu/20mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Heparin sodium 10,000iu/10mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 25,000iu/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Monoparin 10,000iu/10mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Unihep 25,000units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Unihep 10,000units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Unihep 5000units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Unihep 1000units/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ticlid 250mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ticlopidine hydrochloride 250mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|